Fortis Healthcare on Friday said it was in talks with a number of investors to facilitate an exit by the existing private-equity investors from the company's diagnostic arm, SRL Diagnostics.
"The company is in the process of facilitating a third-party exit for the existing private-equity investors in SRL Diagnostics Ltd," Fortis Healthcare said in a filing to the BSE (formerly known as the Bombay Stock Exchange).
Read more from our special coverage on "FORTIS"
The process is on and the company is in dialogue with a number of investors who have shown interest, it added.
"As on date, there is no firm proposal under consideration of the management," Fortis Healthcare said.
It did not elaborate. The stock of Fortis Healthcare on Friday closed at Rs 175 on the BSE, up 12 per cent from its previous close.
